Mekinist tablets 2mg

Mekinist (trametinib) tablets, 2mg (YJ code: 4291047F2022, standard: 2mg 1 tablet), manufactured by Novartis Pharma, are a MEK inhibitor used alone or in combination with dabrafenib (Tafinlar) to treat various BRAF-positive cancers, including melanoma, non-small cell lung cancer, anaplastic thyroid cancer, solid tumors, and low-grade glioma in adults and some children. It works by blocking specific cell signals to inhibit cancer cell growth and proliferation.